Welcome to LookChem.com Sign In|Join Free
  • or
5’-O-Trityluridine-2’,3’-lyxo-epoxide is a synthetic intermediate that plays a crucial role in the development of antiviral agents. It is a modified nucleoside with a trityl group attached to the 5' position and an epoxide group at the 2',3' position, which contributes to its unique chemical properties and potential applications in medicinal chemistry.

96253-10-0

Post Buying Request

96253-10-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

96253-10-0 Usage

Uses

Used in Pharmaceutical Industry:
5’-O-Trityluridine-2’,3’-lyxo-epoxide is used as a synthetic intermediate for the synthesis of various antiviral agents. Its unique structure allows for the development of new compounds with enhanced antiviral activity and selectivity, making it a valuable asset in the fight against viral infections.
In the pharmaceutical industry, 5’-O-Trityluridine-2’,3’-lyxo-epoxide serves as a key building block in the creation of novel antiviral drugs. Its chemical properties enable the design of molecules that can effectively target and inhibit viral replication, providing a promising avenue for the treatment of viral diseases.
Furthermore, 5’-O-Trityluridine-2’,3’-lyxo-epoxide can be utilized in the development of prodrugs, which are inactive compounds that are converted into their active form within the body. This approach can improve the pharmacokinetic properties of antiviral agents, such as their solubility, stability, and bioavailability, ultimately leading to more effective treatments.
Overall, 5’-O-Trityluridine-2’,3’-lyxo-epoxide is a versatile and valuable synthetic intermediate in the pharmaceutical industry, with significant potential for the development of innovative antiviral therapies.

Check Digit Verification of cas no

The CAS Registry Mumber 96253-10-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,6,2,5 and 3 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 96253-10:
(7*9)+(6*6)+(5*2)+(4*5)+(3*3)+(2*1)+(1*0)=140
140 % 10 = 0
So 96253-10-0 is a valid CAS Registry Number.
InChI:InChI=1/C28H24N2O5/c31-23-16-17-30(27(32)29-23)26-25-24(35-25)22(34-26)18-33-28(19-10-4-1-5-11-19,20-12-6-2-7-13-20)21-14-8-3-9-15-21/h1-17,22,24-26H,18H2,(H,29,31,32)/t22-,24-,25-,26-/m1/s1

96253-10-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[2,3-epoxy-5-O-(triphenylmethyl)-β-D-lyxofuranosyl]pyrimidine-2,4(1H,3H)-dione

1.2 Other means of identification

Product number -
Other names 5'-O-TRITYLURIDINE-2',3'-LYXO-EPOXIDE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:96253-10-0 SDS

96253-10-0Relevant academic research and scientific papers

Synthesis of 3′-azido-4′-ethynyl-3′,5′-dideoxy- 5′-norarabinouridine: A new anti-HIV nucleoside analogue

Amin, Mahmoud A.

, p. 1703 - 1708 (2011/04/18)

3′-Azido-4′-ethynyl-3′,5′dideoxy-5′- norarabinouridine 10 was synthesized from commercial uridine 1 in which the key step is the opening of protected 2′,3′-epoxyuridine derivative 7 by sodium azide and the hydroxymethyl at 4-position of the ribose ring are replaced by ethynyl group.

3′-Bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of mycobacterium tuberculosis

Shakya, Neeraj,Srivastav, Naveen C.,Desroches, Nancy,Agrawal, Babita,Kunimoto, Dennis Y.,Kumar, Rakesh

experimental part, p. 4130 - 4140 (2010/09/04)

Tuberculosis (TB) is a major health problem worldwide. We herein report a new class of pyrimidine nucleosides as potent inhibitors of Mycobacterium tuberculosis (M. tuberculosis). Various 2′- or 3′-halogeno derivatives of pyrimidine nucleosides containing uracil, 5-fluorouracil, and thymine bases were synthesized and evaluated for antimycobacterial activities. Among the compounds tested, 3′-bromo-3′-deoxy- arabinofuranosylthymine (33) was the most effective antituberculosis agent in the in vitro assays against wild-type M. tuberculosis strain (H37Ra) (MIC 50 = 1 μg/mL) as well as drug-resistant (H37Rv) (rifampicin-resistant and isoniazid-resistant) strains of M. tuberculosis (MIC50 = 1-2 μg/mL). Compound 33 also inhibited intracellular M. tuberculosis in a human monocytic cell line infected with H37Ra, demonstrating higher activity against intramacrophagic mycobacteria (80% reduction at 10 μg/mL concentration) than extracellular mycobacteria (75% reduction at 10 μg/mL concentration). In contrast, pyrimidine nucleosides possessing 5-fluorouracil base were weak inhibitors of M. tuberculosis. No cytotoxicity was found up to the highest concentration of compounds tested (CC50 > 100-200 μg/mL) against a human cell line. Overall, these encouraging results substantiate the potential of this new class of compounds as promising antituberculosis agents.

Preparation and cleavage reactions of 3′-thiouridylyl-(3′→5′)-uridine

Liu, Xiaohai,Reese, Colin B.

, p. 2227 - 2236 (2007/10/03)

3′-Thiouridylyl-(3′→5′)-uridine [(Us)pU] 3 is prepared by coupling together the disulfide 14 and the 5′-H-phosphonate 18, and then removing the protecting groups. (Us)pU 3 readily undergoes cleavage in 0.05 mol dm-3 sodium glycinate buffer (pH 10.06) at 50 °C to give, in the first instance, uridine 4 and 3′-thiouridine 2′,3′-cyclic phosphorothioate 21; in glacial acetic acid at 30 °C, it rapidly undergoes cleavage in essentially the same way. The behaviour of (Us)pU 3 is compared with that of uridylyl-(3′→5′)-uridine (UPU) 1a under the same basic and acidic reaction conditions. (Us)pU 3 and 3′-thiouridine 2′,3′-cyclic phosphorothioate 21 are both substrates for ribonuclease A; (Us)pU 3 is a substrate for Crotalus adamanteus snake venom phosphodiesterase but not for calf spleen phosphodiesterase.

Synthesis of 2',3'-dideoxy-3'-hydroxymethylcytidine; A unique antiviral nucleoside

Faul, Margaret M.,Huff, Bret E.,Dunlap, Steven E.,Frank, Scott A.,Fritz, James E.,Kaldor, Stephen W.,LeTourneau, Michael E.,Staszak, Michael A.,Ward, Jeffrey A.,Werner, John A.,Winneroski, Leonard L.

, p. 8085 - 8104 (2007/10/03)

The synthesis of 2',3'-dideoxy-3'-hydroxymethylcytidine 1 was accomplished using two different approaches. First, uridine and cytidine were used to prepare the key intermediate epoxides 15 and 31 which were opened with cyanide, deoxygenated by elimination to vinyl nitriles 17 and 36, and reduced by 1,4 hydride addition to the saturated nitriles 18 and 37. Secondly, a novel Rh-catalyzed hydroformylation reaction of 2',3'-didehydro-2',3'-dideoxycytidine 46 was used to prepare 1 in four steps. The attempted use of 2'-deoxyuridine and 2'-deoxycytidine to prepare 1 is also discussed.

Synthesis of 2',3'-Dithiouridine

Johnson, Richard,Joshi, Bhalchandra V.,Reese, Colin B.

, p. 133 - 134 (2007/10/02)

The synthesis of 2',3'-dithiouridine 2, starting from uridine, is described.

Azide- Or fluorine-containing 2′ & 3′-azolyluridines by regioselective opening of 1-(2′,3′-anhydro-β-d-lyxofuranosyl)uracils

Ariza, Xavier,Garces, Josep,Vilarrasa, Jaume

, p. 4069 - 4072 (2007/10/02)

Azide- or fluorine-containing imidazol-1-yl, pyrazol-1-yl, and 1,2,4-triazol-1-yl 2′,3′-dideoxyuridines have been synthesized from uridine in 5-6 steps, via 2′,3′-β-cpoxy ? derivatives. Regioselective oxirane-ring openings have been accomplished by appropriate choice of the reactions conditions.

NOVEL NUCLEOSIDE ANALOGUES VIA DIRECT ATTACK OF CARBON NUCLEOPHILES ON NUCLEOSIDES CONTAINING EPOXY-SUGARS

Mete, A.,Hobbs, J. B.

, p. 97 - 100 (2007/10/02)

Direct ring-opening of the epoxyde ring in 1-(5'-O-tityl-2',3'-anhydro-β-D-lyxofuranosyl) uracil(1) by lithium acetylide or vinylmagnesium bromide/cuprous iodide affords the corresponding 5'-O-trityl-3'-C-substituted-3'-deoxy-ara-uridine species.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 96253-10-0